WASHINGTON (AP) - An innovative hepatitis C drug that was only recently hailed as a breakthrough treatment is facing skepticism from some health care providers, as they consider whether it is worth the $1,000-a-pill price set by manufacturer Gilead Sciences Inc.
Today's headlines include reports that the Centers for Medicare & Medicaid Services is stepping back from proposed changes to the Medicare drug program.
Today's headlines include reports about how the Virginia Assembly's impasse on Medicaid expansion is playing out.
WASHINGTON, March 10, 2014 /PRNewswire/ -- The Corporate Whistleblower Center is urging medical doctors, or pharmaceutical sales representatives to call them at 866-714-6466, if they possess well documented ...
Demand for doctors whether in person or via a computer screen is expected to surge as millions more Americans become insured under the Affordable Care Act. About 10 million people already rely on telemedicine, often from doctors who live in another state.
NASHVILLE, Tenn. and#8212; Even as public attention is focused on the Affordable Care Act, another health care overhaul is underway in many states: an ambitious effort to restrain the ballooning Medicaid cost of long-term care as people live longer and survive more disabling conditions.
EAST LANSING, Mich., March 4, 2014 /PRNewswire/ -- Meridian Health Plan, the largest Medicaid managed care organization (MCO) in the State of Michigan, announced today that Meridian has joined Michigan's collective effort to enable secure, electronic sharing of health information as a new Qualified Data Sharing Organization (QO) with MiHIN, the state-designated entity for the exchange of health ...
Since 2009, the eight states (Alabama, Illinois, Louisiana, Massachusetts, New York, Utah, Virginia, and Wisconsin) participating in the Robert Wood Johnson Foundation's Maximizing Enrollment program have worked to streamline and simplify enrollment systems, policies, and processes for children and those eligible for coverage in 2014. ... States [focused] on five key areas: 1) applications, 2 ...
LITTLE ROCK, Ark. (AP) - A lawyer for two pharmaceutical companies argued Thursday that the Arkansas Supreme Court should reverse a $1.2 billion judgment because the trial judge improperly applied a law in the state's lawsuit over improper marketing of the antipsychotic drug Risperdal.
They are a diverse group of low-income people who are disabled or elderly. Many have multiple chronic illnesses, or are battling depression or substance abuse. Most will need long-term care at some point in their lives.